Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

CLDN18.2 Positive × Gemcitabine × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 32 Urinary Bladder Neoplasms 20 Lymphoma, Large B-Cell, Diffuse 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasm Metastasis 12 Lung Neoplasms 11 Triple Negative Breast Neoplasms 9 Neoplasms 9 Carcinoma, Transitional Cell 8 Ovarian Neoplasms 7 Biliary Tract Neoplasms 7 Non-Muscle Invasive Bladder Neoplasms 6 Nasopharyngeal Carcinoma 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Sarcoma 5 Recurrence 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Lymphoma 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5 Uterine Cervical Neoplasms 3 Urethral Neoplasms 3 Ureteral Neoplasms 3 Lymphoma, Non-Hodgkin 3 Gastrointestinal Neoplasms 3 Gallbladder Neoplasms 3 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Melanoma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡